SIMS $150 MIL ACQUISITION OF DELTEC FROM PHARMACIA
This article was originally published in The Gray Sheet
Executive SummarySIMS $150 MIL ACQUISITION OF DELTEC FROM PHARMACIA gives Smiths Industries Medical Systems a firmer foothold in the home health care market, the firm says. The acquisition was completed in July, and Deltec is now doing business as SIMS Deltec, an operating company of SIMS. Deltec officials say no substantive changes are foreseen in the operation of their company as a result of the acquisition.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.